Sep 27, 2022 / 02:00AM GMT
Presentation
Sep 27, 2022 / 02:00AM GMT
=====================
Corporate Participants
=====================
* Steven Yatomi-Clarke
Prescient Therapeutics Limited - CEO, MD
* Rebecca Lim
Prescient Therapeutics Limited - Senior VP, Scientific Affairs
=====================
Conference Call Participants
=====================
* Patrick Nelson
Reach Markets Pvt Ltd - Moderator
=====================
Patrick Nelson - Reach Markets Pvt Ltd - Moderator
All right. Let's get going. Good afternoon, and welcome to Prescient Therapeutics special investor briefing, which today is going to be focused on the CellPryme-A platform for enhancing cell therapies. My name is Patrick Nelson. I'm the MD at Reach, and I'll be facilitating the webcast today, but we are joined by the Prescient, CEO and Managing Director, Steven Yatomi-Clarke and also the Senior VP of Scientific Affairs, Dr. Rebecca Lim, welcome guys.
And today's session will run sort of -- we know that on the session today, we've got some existing PTX
Prescient Therapeutics Ltd Investor Presentation Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot